Crop Life Science Approves Board Report, Fixes 20th AGM for September 2026
Crop Life Science Limited's Board of Directors, during a meeting held on Monday, August 24, 2026, approved the Board's Report for the financial year ending March 31, 2026, and set the date for the company's 20th Annual General Meeting (AGM).The board meeting, which was held at the Registered Office of the Company, concluded at 1:00 PM, having commenced at 12:10 PM.
Key decisions taken by the Board included the approval of the Board's Report along with all relevant annexures for the financial year that concluded on March 31, 2026.
Annual General Meeting Details
The Board also approved the notice convening the 20th Annual General Meeting (AGM) of the company. This AGM, scheduled for the financial year ended March 31, 2026, is set for September 23, 2026, at 3:30 PM (IST). The meeting will be conducted through Video Conferencing (VC) or another Audio-Visual Means (OAVM).Other Board Decisions
During the meeting, the board considered the proposal concerning the incorporation of a wholly-owned subsidiary outside India and the proposed investment therein. The board decided to defer this matter for further evaluation and did not reach a final decision on the proposal at the meeting.Additionally, the company appointed Mr. Ranjit Kumar Singh of M/s. Ranjit & Associates, a Practicing Company Secretary in Vadodara, to serve as the Scrutinizer. The appointed scrutinizer is responsible for overseeing the entire e-voting process of the AGM, including remote e-voting, to ensure fairness and transparency.
CLSL Stock Price Movement
Shares of Crop Life Science Limited shed value today, slipping 4.94% to settle at ₹76.05 in post-market trading. The stock traded a volume of 4,000 shares during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.